COM:LUCIRAHEALTH
Lucira Health
- Stock
Last Close
0.45
03/03 21:00
Market Cap
18.36M
Beta: -
Volume Today
36.26M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|
average inventory | 2.43M - | 27.82M 1,043.70% | |||
average payables | 748.50K - | 2.28M 204.07% | 11.68M 413.01% | ||
average receivables | 2.13M - | 1.13M 46.84% | 17.95M 1,482.59% | ||
book value per share | -2.22 - | -1.67 24.94% | -1.74 4.25% | 5.43 412.59% | |
capex per share | -0.02 - | -0.00 73.61% | -0.52 10,670.60% | -0.44 15.60% | |
capex to depreciation | -0.59 - | -0.27 54.80% | -67.19 25,251.41% | -4.19 93.76% | |
capex to operating cash flow | 0.02 - | 0.01 52.97% | 0.58 5,346.25% | 0.15 73.62% | |
capex to revenue | -69.93 - | -0.17 99.76% | |||
cash per share | 0.01 - | 0.27 2,071.63% | 1.62 509.67% | 3.05 87.82% | |
days of inventory on hand | 914.85 - | 223.75 75.54% | |||
days payables outstanding | 748.62 - | 85.36 88.60% | |||
days sales outstanding | 645.87 - | 138.98 78.48% | |||
debt to assets | 5.11 - | 4.37 14.45% | 1.67 61.77% | 0.21 87.17% | |
debt to equity | -1.24 - | -1.30 4.28% | -2.49 91.90% | 0.27 110.98% | |
dividend yield | |||||
earnings yield | -0.03 - | -0.02 28.15% | -0.05 110.75% | -0.22 332.48% | |
enterprise value | 201.83M - | 381.74M 89.14% | 863.26M 126.14% | 196.20M 77.27% | |
enterprise value over ebitda | -33.10 - | -51.45 55.42% | -29.26 43.12% | -3.22 88.98% | |
ev to operating cash flow | -31.22 - | -54.06 73.15% | -26.54 50.90% | -1.94 92.67% | |
ev to sales | 3.21K - | 2.11 99.93% | |||
free cash flow per share | -0.84 - | -0.46 44.53% | -1.43 208.87% | -3.34 133.64% | |
free cash flow yield | -0.03 - | -0.02 44.53% | -0.06 208.87% | -0.39 577.86% | |
graham net net | -2.51 - | -1.81 28.11% | -2.62 45.07% | 3.06 216.75% | |
graham number | 6.42 - | 4.72 26.56% | 6.99 48.22% | 15.09 115.86% | |
income quality | 0.99 - | 0.83 15.68% | 0.87 4.41% | 1.56 78.69% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -51.66 - | -153.98 198.07% | -602.36 291.20% | -21.51K 3,471.52% | |
interest debt per share | 0.56 - | 0.08 86.15% | 0.71 814.56% | 0.08 88.57% | |
inventory turnover | 0.40 - | 1.63 308.88% | |||
invested capital | -0.24 - | -0.04 82.16% | -0.41 846.45% | 0.01 103.66% | |
market cap | 197.66M - | 384.73M 94.64% | 895.96M 132.88% | 299.36M 66.59% | |
net current asset value | -19.15M - | -27.14M 41.70% | -84.78M 212.39% | 154.73M 282.51% | |
net debt to ebitda | -0.68 - | 0.40 159.02% | 1.11 175.14% | 1.70 52.89% | |
net income per share | -0.83 - | -0.59 28.15% | -1.25 110.75% | -1.86 49.07% | |
operating cash flow per share | -0.82 - | -0.46 43.88% | -0.91 97.76% | -2.90 219.97% | |
payables turnover | 0.49 - | 4.28 777.02% | |||
receivables turnover | 0.57 - | 2.63 364.71% | |||
research and ddevelopement to revenue | 91.52 - | 0.43 99.53% | |||
return on tangible assets | -1.53 - | -1.20 21.46% | -0.48 59.73% | -0.27 44.27% | |
revenue per share | 0.01 - | 2.68 35,586.05% | |||
roe | 0.37 - | 0.36 4.27% | 0.72 102.16% | -0.34 147.69% | |
roic | -3.11 - | 12.85 512.77% | 1.38 89.23% | -7.16 617.06% | |
sales general and administrative to revenue | |||||
shareholders equity per share | -2.22 - | -1.67 24.94% | -1.74 4.25% | 5.43 412.59% | |
stock based compensation to revenue | 1.62 - | 0.09 94.64% | |||
tangible asset value | -17.57M - | -25.66M 46.09% | -62.31M 142.77% | 188.80M 403.02% | |
tangible book value per share | -2.22 - | -1.67 24.94% | -1.74 4.25% | 5.43 412.59% | |
working capital | -2.81M - | 4.53M 261.51% | 61.37M 1,254.24% | 155.95M 154.10% |
All numbers in USD (except ratios and percentages)